Atlas Trials

Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome

Clinical trial NCT01873703 · COMPLETED

Trial details

NCT number
NCT01873703
Sponsor
Helsinn Healthcare SA
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndrome
Start date
2013-06-01
Primary completion
2015-11-01
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.